Omar Ahmed F, Silva Paolo S, Sun Jennifer K
Joslin Diabetes Center, Beetham Eye Institute , Boston, Massachusetts , USA and.
Semin Ophthalmol. 2013 Sep-Nov;28(5-6):337-46. doi: 10.3109/08820538.2013.825287.
Multiple studies have shown that genetic factors may play an important role in determining an individual's risk for the development of diabetic retinopathy (DR) and progression to proliferative DR. However, consistent and definitive genetic associations with DR across broad populations have been not been established. Numerous genes have been studied for their association with DR and the results of these investigations have most specifically pointed to three specific genes that are likely involved in DR development and progression. The gene coding for vascular endothelial growth factor, aldose reductase, and the receptor for advanced glycation end products have been extensively evaluated, and specific polymorphisms of these genes have been suggested to potentially increase the risk of DR development. In this paper, we have reviewed the published literature on the genetics of DR and the potential implications for DR development and progression.
多项研究表明,遗传因素在决定个体患糖尿病视网膜病变(DR)的风险以及进展为增殖性DR的过程中可能起重要作用。然而,尚未在广泛人群中建立与DR一致且明确的遗传关联。许多基因已被研究其与DR的关联,这些研究结果最具体地指向了三个可能参与DR发生和发展的特定基因。编码血管内皮生长因子、醛糖还原酶和晚期糖基化终产物受体的基因已得到广泛评估,这些基因的特定多态性被认为可能增加患DR的风险。在本文中,我们回顾了关于DR遗传学的已发表文献及其对DR发生和发展的潜在影响。